Sorafenib, Tamoxifen, and Cisplatin in Treating Patients With High-Risk Stage III Melanoma
Clinical trial NCT00492505 · UNKNOWN
Trial details
- NCT number
- NCT00492505
- Sponsor
- San Diego Pacific Oncology & Hematology Associates
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-04-01
- Primary completion
- 2011-12-01
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.